European Archives - Page 1096 of 1104 - European Medical Journal

Oligodendrogenesis After Cerebral Ischaemia and Traumatic Brain Injury

Stroke and traumatic brain injury (TBI) damage white and grey matter. Loss of oligodendrocytes and their myelin, impairs axonal function.

Mode of Delivery in Multiple Sclerosis

Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system, affecting women of childbearing age. Little is known about…

Neurorehabilitation After Stroke

Recovery from ischaemic stroke is determined in the acute phase by the lesion impact of ischaemia and subsequently, by functional and structural network…

Current Essentials in Inflammatory Myopathies

Inflammatory myopathies are a heterogeneous group of acquired systemic diseases, which include dermatomyositis (DM), polymyositis (PM), necrotising…

Fertility Preservation Options for Cancer Patients

Survival rates for cancer patients have increased in the last few years due to improvements achieved in cancer therapies.

Evidence-Based Treatment Planning in mCRC: The Key to Maximising Outcomes

This Roche sponsored satellite symposium was held as part of the European Cancer Congress 2013, and reviewed the current evidence available on treatment…

EMJ Oncology 2013

I am very excited to introduce to you our inaugural edition of European Medical Journal – Oncology.

The Future of Chronic Lymphocytic Leukaemia Treatment: Balancing Efficacy, Safety and Cost

A Review of the Mundipharma International Ltd Organised Symposium, at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL), Cologne…

Extreme Hypofractionated Image-Guided Radiotherapy for Prostate Cancer

An emerging body of data suggests that hypofractionated radiation schedules, where a higher dose per fraction is delivered in a smaller number of…

Prostate Cancer and Inflammation: The Role of miRNAs

Approximately 15-20% of all human cancers are assumed to be a result of infection and chronic inflammation due to a constant supply of cytokines and…